Literature DB >> 25040598

Plasma free triiodothyronine (fT3) levels in baboons undergoing pig organ transplantation: relevance to early recovery of organ function.

Hayato Iwase1, Burcin Ekser1, Vikas Satyananda1, Mohamed Ezzelarab1, David K C Cooper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25040598      PMCID： PMC4262746          DOI： 10.1111/xen.12117

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN： 0908-665X            Impact factor:   3.907


× No keyword cloud information.
  10 in total

1.  Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs.

Authors:  D Novitzky; P A Human; D K Cooper
Journal:  Ann Thorac Surg       Date:  1988-01       Impact factor: 4.330

2.  Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy.

Authors:  D Novitzky; D K Cooper; D Morrell; S Isaacs
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

3.  Cardiopulmonary bypass: a low T4 and T3 syndrome with blunted thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH).

Authors:  G Robuschi; D Medici; F Fesani; G Barboso; M Montermini; L d'Amato; E Gardini; E Borciani; E Dall'Aglio; M Salvi
Journal:  Horm Res       Date:  1986

4.  Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors.

Authors:  D Novitzky; D K Cooper; B Reichart
Journal:  Transplantation       Date:  1987-06       Impact factor: 4.939

5.  Hypothalamo-pituitary-thyroid axis function during cardiopulmonary bypass.

Authors:  W F Bremner; K M Taylor; S Baird; J E Thomson; J A Thomson; J G Ratcliffe; T D Lawrie; W H Bain
Journal:  J Thorac Cardiovasc Surg       Date:  1978-03       Impact factor: 5.209

6.  Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: a retrospective analysis.

Authors:  Dimitri Novitzky; Zhibao Mi; Qing Sun; Joseph F Collins; David K C Cooper
Journal:  Transplantation       Date:  2014-11-27       Impact factor: 4.939

7.  Triiodothyronine therapy for heart donor and recipient.

Authors:  D Novitzky; D K Cooper; P A Human; B Reichart; N Zuhdi
Journal:  J Heart Transplant       Date:  1988 Sep-Oct

Review 8.  Cardiac xenotransplantation: progress and challenges.

Authors:  Guerard W Byrne; Christopher G A McGregor
Journal:  Curr Opin Organ Transplant       Date:  2012-04       Impact factor: 2.640

9.  Effect of triiodothyronine (T3) on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass. An experimental study in baboons.

Authors:  D Novitzky; P A Human; D K Cooper
Journal:  J Thorac Cardiovasc Surg       Date:  1988-10       Impact factor: 5.209

10.  Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery.

Authors:  D Novitzky; D K Cooper; A Swanepoel
Journal:  Eur J Cardiothorac Surg       Date:  1989       Impact factor: 4.191
  10 in total
  3 in total

Review 1.  Overcoming Coagulation Dysregulation in Pig Solid Organ Transplantation in Nonhuman Primates: Recent Progress.

Authors:  Liaoran Wang; David K C Cooper; Lars Burdorf; Yi Wang; Hayato Iwase
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

2.  Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts.

Authors:  Hayato Iwase; Hidetaka Hara; Mohamed Ezzelarab; Tao Li; Zhongqiang Zhang; Bingsi Gao; Hong Liu; Cassandra Long; Yi Wang; Amy Cassano; Edwin Klein; Carol Phelps; David Ayares; Abhinav Humar; Martin Wijkstrom; David K C Cooper
Journal:  Xenotransplantation       Date:  2017-03-17       Impact factor: 3.907

3.  Thyroid hormone: relevance to xenotransplantation.

Authors:  Hayato Iwase; Burcin Ekser; Hidetaka Hara; Mohamed B Ezzelarab; Cassandra Long; Angus W Thomson; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2016-07-04       Impact factor: 3.907
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.